Kris Cameron Wood

Kris Cameron Wood

Associate Professor of Pharmacology and Cancer Biology

Our laboratory uses genomic and pharmacological approaches to understand how tumor dependencies are shaped by cell intrinsic factors, environmental factors, and drug treatments during the dynamic process of tumor evolution. To learn more, please visit our laboratory website: https://woodlabduke.com/.

Appointments and Affiliations

  • Associate Professor of Pharmacology and Cancer Biology
  • Associate Professor of Cell Biology
  • Core Faculty in Innovation & Entrepreneurship
  • Member of the Duke Cancer Institute

Contact Information

  • Email Address: kris.wood@duke.edu
  • Websites:

Education

  • Ph.D. Massachusetts Institute of Technology, 2007

Courses Taught

  • UPGEN 778A: University Program in Genetics and Genomics Biological Solutions Module I
  • PHARM 818: Molecular Mechanisms of Oncogenesis
  • PHARM 495: Research Independent Study
  • PHARM 494: Research Independent Study
  • PHARM 493: Research Independent Study
  • PHARM 394: Research Independent Study
  • PHARM 393: Research Independent Study
  • MOLCAN 818: Molecular Mechanisms of Oncogenesis
  • CMB 710E: Cell & Molecular Biology Module V
  • CMB 710B: Cell & Molecular Biology Module II

In the News

Representative Publications

  • Gilmer, TM; Lai, C-H; Guo, K; Deland, K; Ashcraft, KA; Stewart, AE; Wang, Y; Fu, J; Wood, KC; Kirsch, DG; Kastan, MB, Figure S2 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors (2024) [10.1158/1535-7163.25964832] [abs].
  • Gilmer, TM; Lai, C-H; Guo, K; Deland, K; Ashcraft, KA; Stewart, AE; Wang, Y; Fu, J; Wood, KC; Kirsch, DG; Kastan, MB, Table S4 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors (2024) [10.1158/1535-7163.25964793.v1] [abs].
  • Gilmer, TM; Lai, C-H; Guo, K; Deland, K; Ashcraft, KA; Stewart, AE; Wang, Y; Fu, J; Wood, KC; Kirsch, DG; Kastan, MB, Kinase Panel 1 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors (2024) [10.1158/1535-7163.25964811.v1] [abs].
  • Gilmer, TM; Lai, C-H; Guo, K; Deland, K; Ashcraft, KA; Stewart, AE; Wang, Y; Fu, J; Wood, KC; Kirsch, DG; Kastan, MB, Table S4 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors (2024) [10.1158/1535-7163.25964793] [abs].
  • Gilmer, TM; Lai, C-H; Guo, K; Deland, K; Ashcraft, KA; Stewart, AE; Wang, Y; Fu, J; Wood, KC; Kirsch, DG; Kastan, MB, Figure S6 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors (2024) [10.1158/1535-7163.25964820] [abs].